Skip to main content
. 2024 Jul 22;20(9):5901–5911. doi: 10.1002/alz.14060

TABLE 1.

Demographic and clinical characteristics of the sample.

Parameter

All

N = 423

Age, years 57 ± 10
Female, n (%) 213 (50%)

Race and ethnicity, n (%)

Non‐Hispanic White

Unknown

421 (>99%)

2 (<1%)

Education, n (%)

No college degree

College degree or higher

148 (35%)

275 (65%)

APOE ε4 allele, n (%) 95 (23%)
Interval between cognitive testing and PET Imaging, years 0.2 ± 0.2
Verbal memory a

(N = 413)

0.00 ± 1.00

Visual memory a

(N = 419)

0.00 ± 1.00

Attention/executive a

(N = 406)

0.00 ± 1.00

Language a

(N = 394)

0.00 ± 1.00

Visuospatial a

(N = 419)

0.00 ± 1.00

Global cognition a

(N = 397)

0.00 ± 1.00

Aβ Centiloid, n (%)

<20

20‐39

≥40

(N = 403)

380 (94%)

14 (4%)

9 (2%)

Global Aβ, DVR

(N = 414)

1.08 ± 0.11

Entorhinal tau, SUVR

(N = 322)

1.05 ± 0.09

Rhinal tau, SUVR

(N = 317)

1.10 ± 0.10

Inferior temporal tau, SUVR

(N = 322)

1.14 ± 0.08

Middle temporal tau, SUVR

(N = 322)

1.09 ± 0.08

Fusiform tau, SUVR

(N = 322)

1.14 ± 0.08

Note: Values represent mean ± standard deviation unless otherwise noted.

Abbreviations: Aβ, amyloid beta, APOE, apolipoprotein E, DVR, distribution volume ratio, PET, positron emission tomography, SUVR, standardized uptake value ratio.

a

Values standardized to z‐scores.